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Background: The confusion of clinical and radiological pul-
onary coccidioidomycosis with other respiratory diseases such
s neoplasms, other fungal and bacterial diseases especially tuber-
ulosis, requires the generation of information to guide medical
ersonnel for the diagnosis and treatment on this disease. This
ungal infection is acquired when susceptible hosts inhale arthro-
onidia that are the infectious propagules of the saprobia phase of
his fungus; spherules containing endospores are the typical para-
itic formof Coccidioides immitis and C. posadasii. Howevermycelial
orms have been observed in the parasitic phase of this fungus con-
idered dimorphic. Objective: To describe the clinical, mycological,
adiological and epidemiological characteristics, of patients with
occidioidomycosis.
Methods: Retrospective analysis of clinical data, mycological,
adiological and epidemiological studies of 37 patients. The study
ocused on the presence of hyphae or spherules as parasitic forms.
nclusion criteria were: patients with clinical and laboratory diag-
osis of coccidioidomycosis, incomplete records were excluded.
Results: A differential picture produced by the presence of
pherules (cough, fever, dyspnea, pneumonic image, nodules and
icronodules) of that which occurs in patients with hyphae
chronic disease, weight loss, hemoptysis, cavitary lesion). 26.8% of
atients were receiving amphotericin B and itraconazole, combi-
ations of these with ketoconazole and ﬂuconazole were manifold.
igniﬁcant facts: history of exposure by residence, co-morbidity
nd prolonged hospital stay.
Conclusion: The micro habitat in the cavity lesion in diabetic
atients promotes coexistence of hyphae and spherules of Coccid-
oides, chronic conditions the latter one increases the burden of
isease and the likelihood of hemoptysis. The different antifungal
chemes showed no association with decreased hospital stay.
Thanks: Thiswork is part of theprojectHEALTH-2011-1-161897
Genotypic And Phenotypic Characterization Of Coccidioides Mex-
can Population And Its Relationship With Parasitic Forms”
upported by CONACYT.
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Background: Trichosporon fungemia (TF) has emerged as a fatal
infectious complicaton in patients with hematological malignan-
cies. Although thereare a fewreportsdescribing the responsiveness
of azoles in the treatment of TF in such patients, the utility of ther-
apy with this type of agents has not been fully evaluated so far. The
aim of this study is to assess the clinical efﬁcacy of azoles for TF in
detail in patients with acute leukemia.
Methods: We retrospectively reviewed consecutive 16 adult
patients with acute leukemia who received azole containing ther-
apies for TF at our collaborating 5 hospitals in Japan until 2010,
and assessed the effectiveness of each azole as an anti-Trichosporon
agent by comparing clinical and in-vito antifungal susceptibility
data between cases with therapeutic success and failure.
Results: All 16 patients were neutropenic (<0.5×109/L) mainly
due to intensive chemotherapy at the onset of TF, and among
them only 7 patients had neutophil recovery. Patients were given
miconazole (MCZ), ﬂuconazole (FLCZ), itraconazole, voriconazole
(VCZ), amphotericin B (AmB), 5-ﬂuorocytosine or a combination
of these agents. Seven patients were successfully treated and the
remaining showed therapeutic failures. Five of 7 successfull cases
receivedAmBplusazole: voriconazole (VCZ)andﬂuconazole (FLCZ)
in one each, miconazole (MCZ) plus FLCZ in one, and MCZ in two,
and 2 of them received azole alone: VCZ andMCZ in one each. Ther-
apy regimen for cases with failure were almost the same as that for
cases with success except for the use of VCZ. However, most cases
with failure died within 10 days after the onset of TF. Six of cases
with success hadneutorphil recovery, but it tookmore than10days
for the neutrphil count to exceed 0.5×109/L. Minimal inhibitory
concentrations (MICs) of azoles (FLCZ and MCZ) for isolates were
low in successful cases and relatively higher in failed cases.
Conclusion: Although neutrophil increase was closely associ-
ated with the resolurion of TF, effective control of TF using azole
with a low MIC for isolates also seemed to play a role to provide the
time neccessary for bone marrow restration. Therefore, therapies
with azole possessing a potent anti-Trichosporon activity may be
critical for treating TF in patients with acute leukemia irrespective
of the persistence of neutropenia.
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